Velicept Therapeutics, Inc. logo

Velicept Therapeutics, Inc.

Velicept Therapeutics, Inc. is a privately held, clinical development company focused on advancing best-in-class compounds with the potential to fill unmet medical needs. Its lead program, solabegron, is a highly differentiated novel compound being investigated for overactive bladder (OAB) and irritable bowel syndrome (IBS).

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.velicept.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
101 Lindenwood Drive, Suite 400, PA 19355
Malvern
United States
Email
Contact Number
+1 484-318-2988

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/velicept-therapeutics-inc” connections=”true” suffix=””]